Routine employee equity grant with no immediate trading signal. Monitor for any future insider sales that may follow vesting, but this filing alone does not warrant a position change.
Price Chart
Executive Summary
Genmab granted 13,794 restricted stock units and 13,331 warrants to employees as routine equity compensation. The RSUs have a fair value of DKK 2,268 per unit and vest over three years; warrants have an exercise price of DKK 2,268 and a Black-Scholes fair value of DKK 781.96, vesting after three years and expiring at the seventh anniversary. This is a standard compensation event with no material financial impact on the company's operations or stock price.
Key Facts
- Board granted 13,794 RSUs and 13,331 warrants to employees
- RSU fair value: DKK 2,268 per unit (closing price on grant date)
- Warrant exercise price: DKK 2,268; Black-Scholes fair value: DKK 781.96
- RSUs vest after three years; warrants vest after three years and expire at seven years
Financial Impact
Total potential dilution from RSUs and warrants is approximately 27,125 shares, a negligible fraction of outstanding shares. No cash proceeds to the company from RSUs; warrants may yield up to DKK 30.2 million (approx. $4.5M) if fully exercised.
Risk Factors
- Minimal dilution from RSUs and warrants over vesting period
- No material risk to current valuation
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001434265-26-000125 |
| Document: gmab_20260924x6k.htm | 0001434265-26-000125 |
| Document: 0001434265-26-000125-index-headers.html | 0001434265-26-000125 |
| Document: 0001434265-26-000125-index.html | 0001434265-26-000125 |
| Document: 0001434265-26-000125.txt | 0001434265-26-000125 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 28, 2026 1d ago | 6-K | $57.29 $56.49 | ▼ −1.40% | ▼ −1.01% | $56.49 (−1.40%) |
Oct 23, 2026 6d ago | 6-K | $43.79 $44.69 | ▲ +2.04% | ▲ +1.33% | $56.49 (+29.00%) |
Oct 13, 2026 17d ago | 6-K | $36.57 $36.89 | ▲ +0.88% | ▲ +1.96% | $56.49 (+54.47%) |
Oct 7, 2026 22d ago | 6-K | $36.65 $36.05 | ▼ −1.64% | ▼ −1.21% | $56.49 (+54.13%) |
Oct 5, 2026 24d ago | SC 13G | $37.80 $36.65 | ▼ −3.04% | ▼ −2.80% | $56.49 (+49.44%) |
Oct 5, 2026 24d ago | 6-K | $38.48 $37.80 | ▼ −1.77% | ▼ −2.32% | $56.49 (+46.80%) |
Oct 2, 2026 27d ago | 6-K | $34.75 $38.48 | ▲ +10.73% | ▲ +10.06% | $56.49 (+62.56%) |
Sep 29, 2026 4w ago | 6-K | $35.57 $35.68 | ▲ +0.30% | ▲ +0.50% | $56.49 (+58.81%) |
Sep 24, 2026 5w ago | 6-K | $34.83 $35.32 | ▲ +1.41% | ▲ +0.86% | $56.49 (+62.19%) |
Sep 8, 2026 7w ago | 6-K | $33.53 $33.04 | ▼ −1.46% | ▼ −1.00% | $56.49 (+68.48%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers